Medigen Biotechnology Corp. (3176.TWO)
TWD 26.25
(-8.7%)
TWD 26.25
(-8.7%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.85 Billion TWD | 0.58% |
| 2022 | 1.74 Billion TWD | -0.29% |
| 2021 | 1.74 Billion TWD | 53.02% |
| 2020 | 1.14 Billion TWD | 15.96% |
| 2019 | 983.47 Million TWD | 16.79% |
| 2018 | 842.11 Million TWD | 14.66% |
| 2017 | 734.43 Million TWD | -8.71% |
| 2016 | 804.5 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 233.55 Million TWD | -15.18% |
| 2024 Q1 | 275.34 Million TWD | -61.9% |
| 2023 Q3 | 302.38 Million TWD | -33.72% |
| 2023 FY | 1.75 Billion TWD | 0.58% |
| 2023 Q1 | 317.05 Million TWD | -21.94% |
| 2023 Q4 | 722.72 Million TWD | 139.01% |
| 2023 Q2 | 456.23 Million TWD | 43.9% |
| 2022 Q1 | 450.29 Million TWD | -7.5% |
| 2022 FY | 1.74 Billion TWD | -0.29% |
| 2022 Q4 | 406.17 Million TWD | -13.97% |
| 2022 Q3 | 472.13 Million TWD | 14.75% |
| 2022 Q2 | 411.44 Million TWD | -8.63% |
| 2021 Q3 | 327.58 Million TWD | 0.0% |
| 2021 FY | 1.74 Billion TWD | 53.02% |
| 2021 Q4 | 486.79 Million TWD | 48.6% |
| 2020 FY | 1.14 Billion TWD | 15.96% |
| 2019 FY | 983.47 Million TWD | 16.79% |
| 2018 FY | 842.11 Million TWD | 14.66% |
| 2017 FY | 734.43 Million TWD | -8.71% |
| 2016 FY | 804.5 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -1349.379% |
| Level Biotechnology Inc. | 151.99 Million TWD | -1117.439% |
| Sagittarius Life Science Corp | 135.85 Million TWD | -1262.077% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | -2339.291% |
| TaiMed Biologics Inc. | 225.23 Million TWD | -721.559% |
| GlycoNex Incorporation | 995 Thousand TWD | -185872.06% |
| VBI | 32.55 Million TWD | -5583.987% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | -620.376% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -852.912% |
| Visgeneer Inc. | 67.48 Million TWD | -2642.097% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 593.195% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | -262.76% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -2795.673% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | -28.141% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -6204.245% |
| Enimmune corporation | 220.1 Million TWD | -740.711% |
| TaiRx, Inc. | 217.13 Million TWD | -752.203% |
| CHO Pharma, Inc. | 268.99 Million TWD | -587.894% |
| EirGenix Inc. | 236.74 Million TWD | -681.623% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -1673.267% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | -417.424% |
| Lin BioScience, Inc. | 1.09 Billion TWD | -68.707% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | -595.232% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -3640.418% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -170760.757% |
| Lukas Biomedical Inc. | 177.45 Million TWD | -942.785% |
| RBC Bioscience Corporation | 58.35 Million TWD | -3070.92% |
| BiOptic Inc. | 108.69 Million TWD | -1602.445% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -2055924.444% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -2568.236% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -70661.836% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | -187.369% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -562338.298% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -3920.646% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -1443.176% |
| Neith Corporation | 66.87 Million TWD | -2667.069% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -1882.538% |
| NaviFUS Corp. | 11.82 Million TWD | -15545.743% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -870.184% |
| Sinew Pharma Inc. | 186.25 Million TWD | -893.499% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -2399.793% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -739.582% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -4360.891% |
| AP Biosciences Inc | 32.25 Million TWD | -5637.209% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -34985.741% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | -483.133% |
| Intech Biopharm Corporation | -163.99 Million TWD | 1228.34% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | -63.872% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -4360.783% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | -991.334% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -1158.602% |
| TCI GENE Inc. | 174.61 Million TWD | -959.703% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -10280022.222% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | -514.885% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | -535.978% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -2104.327% |
| PharmaEngine, Inc. | 441.78 Million TWD | -318.847% |
| Savior Lifetec Corporation | 223.36 Million TWD | -728.415% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | -615.059% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 8.227% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -1232.485% |
| Acepodia, Inc. | 452.56 Million TWD | -308.872% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | -242.077% |